Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00002649 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

206

Enrollment

NIH

Sponsor class

Conditions

Recurrent Adult Burkitt Lymphoma
Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Adult Diffuse Mixed Cell Lymphoma
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
Recurrent Adult Immunoblastic Large Cell Lymphoma
Recurrent Grade 1 Follicular Lymphoma
Recurrent Grade 2 Follicular Lymphoma
Recurrent Grade 3 Follicular Lymphoma

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: etoposide
RADIATION: radiation therapy
PROCEDURE: peripheral blood stem cell transplantation
PROCEDURE: bone marrow ablation with stem cell support

Sponsor

National Cancer Institute (NCI)